Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of glucose mediated signaling pathway. [GO_REF:0000058, GOC:di, GOC:TermGenie, PMID:24277933]
Positive regulation of glucose-mediated signaling pathway involves a complex interplay of cellular mechanisms that control the response of cells to glucose levels. This process is essential for maintaining glucose homeostasis and ensuring proper cellular function. Here is a detailed breakdown:
**1. Glucose Sensing and Uptake:**
* Cells detect extracellular glucose levels through specific receptors on their surface.
* Insulin, a key hormone in glucose regulation, plays a crucial role. When blood glucose levels rise, the pancreas releases insulin, which binds to its receptors on target cells.
* Insulin binding activates intracellular signaling cascades that enhance glucose uptake through glucose transporters (GLUTs) located in the cell membrane.
**2. Glucose Metabolism:**
* Once inside the cell, glucose is metabolized through glycolysis, a series of enzymatic reactions that break down glucose into pyruvate.
* Pyruvate is then transported to the mitochondria, where it enters the citric acid cycle and oxidative phosphorylation.
* These processes generate ATP, the cell's primary energy source.
**3. Insulin Signaling Pathway:**
* Insulin receptor activation triggers a cascade of phosphorylation events involving downstream signaling molecules.
* The insulin receptor substrate (IRS) proteins are key intermediates in this pathway.
* These events lead to the activation of phosphatidylinositol 3-kinase (PI3K), which phosphorylates and activates protein kinase B (AKT).
* AKT plays a central role in promoting glucose uptake, glycogen synthesis, and inhibiting gluconeogenesis (glucose production).
**4. Transcriptional Regulation:**
* Insulin signaling also affects gene expression.
* AKT can activate transcription factors like sterol regulatory element-binding protein 1c (SREBP-1c), which promotes the expression of genes involved in lipid and glucose metabolism.
* This transcriptional regulation fine-tunes cellular responses to glucose levels.
**5. Feedback Mechanisms:**
* Negative feedback loops are essential for maintaining homeostasis.
* High glucose levels suppress insulin secretion from the pancreas, preventing excessive insulin signaling.
* Glucose metabolism itself also provides feedback, as the products of glycolysis and the citric acid cycle can modulate downstream signaling pathways.
**6. Dysregulation and Disease:**
* Dysregulation of positive regulation of glucose-mediated signaling pathway can contribute to metabolic disorders.
* Insulin resistance, a condition where cells fail to respond properly to insulin, is a hallmark of type 2 diabetes.
* Other conditions, such as obesity and metabolic syndrome, are also linked to disturbances in glucose signaling.
**In summary, positive regulation of glucose-mediated signaling pathway involves a delicate balance of glucose sensing, uptake, metabolism, insulin signaling, transcriptional regulation, and feedback mechanisms. This intricate process ensures proper glucose homeostasis and supports vital cellular functions. Its dysregulation can lead to serious metabolic disorders.**'"
Protein | Definition | Taxonomy |
---|---|---|
Transcription activator BRG1 | A transcription activator BRG1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51532] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
pf-06687252 | PF-06687252: a SMARCA2/4 bromodomain inhibitor; structure in first source PFI-3 : An azabicycloalkane that is (1R,4R)-2,5-diazabicyclo[2.2.1]heptane which is substituted at position 2 by a 3-(2-hydroxyphenyl)-3-oxoprop-1-en-1-yl group and at position 5 by a pyridin-2-yl group. It is a potent and selective inhibitor of polybromo 1 (Kd = 48 nM), SMARCA2 and SMARCA4 (Kd = 89 nM) bromodomains. | azabicycloalkane; enone; phenols; pyridines |